Vanguard Group
FBRX icon

Vanguard Group’s Forte Biosciences FBRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$6.3M Buy
486,919
+397,968
+447% +$5.15M ﹤0.01% 3128
2025
Q1
$690K Buy
88,951
+62,557
+237% +$485K ﹤0.01% 3811
2024
Q4
$599K Hold
26,394
﹤0.01% 3892
2024
Q3
$148K Sell
26,394
-638,836
-96% -$3.58M ﹤0.01% 4168
2024
Q2
$357K Hold
665,230
﹤0.01% 4075
2024
Q1
$463K Hold
665,230
﹤0.01% 4033
2023
Q4
$547K Buy
665,230
+400
+0.1% +$329 ﹤0.01% 4001
2023
Q3
$440K Hold
664,830
﹤0.01% 4094
2023
Q2
$691K Buy
664,830
+17,282
+3% +$18K ﹤0.01% 4017
2023
Q1
$654K Hold
647,548
﹤0.01% 4040
2022
Q4
$648K Buy
647,548
+255
+0% +$255 ﹤0.01% 4034
2022
Q3
$692K Buy
647,293
+186,159
+40% +$199K ﹤0.01% 4114
2022
Q2
$599K Buy
461,134
+242,051
+110% +$314K ﹤0.01% 4240
2022
Q1
$320K Sell
219,083
-303,047
-58% -$443K ﹤0.01% 4463
2021
Q4
$1.12M Sell
522,130
-36,707
-7% -$78.5K ﹤0.01% 4240
2021
Q3
$1.65M Buy
558,837
+32,319
+6% +$95.7K ﹤0.01% 4115
2021
Q2
$17.7M Buy
526,518
+77,225
+17% +$2.6M ﹤0.01% 2913
2021
Q1
$15.4M Buy
449,293
+5,449
+1% +$187K ﹤0.01% 2929
2020
Q4
$16.2M Buy
443,844
+278,772
+169% +$10.1M ﹤0.01% 2742
2020
Q3
$8.01M Buy
165,072
+104,328
+172% +$5.06M ﹤0.01% 2895
2020
Q2
$886K Sell
60,744
-930,017
-94% -$13.6M ﹤0.01% 3639
2020
Q1
$1.21M Sell
990,761
-2,640
-0.3% -$3.22K ﹤0.01% 3442
2019
Q4
$530K Sell
993,401
-10,716
-1% -$5.72K ﹤0.01% 3784
2019
Q3
$665K Sell
1,004,117
-64,018
-6% -$42.4K ﹤0.01% 3755
2019
Q2
$7.14M Buy
1,068,135
+6,260
+0.6% +$41.8K ﹤0.01% 3042
2019
Q1
$11.5M Buy
1,061,875
+142,189
+15% +$1.55M ﹤0.01% 2752
2018
Q4
$7.55M Buy
919,686
+132,136
+17% +$1.08M ﹤0.01% 2906
2018
Q3
$12.3M Buy
787,550
+101,874
+15% +$1.59M ﹤0.01% 2815
2018
Q2
$6.41M Buy
685,676
+14,386
+2% +$134K ﹤0.01% 3118
2018
Q1
$7.96M Buy
671,290
+23,712
+4% +$281K ﹤0.01% 2942
2017
Q4
$6.64M Buy
647,578
+211,940
+49% +$2.17M ﹤0.01% 3019
2017
Q3
$5.43M Buy
435,638
+16,942
+4% +$211K ﹤0.01% 3087
2017
Q2
$5.04M Buy
+418,696
New +$5.04M ﹤0.01% 3083